The role of hyperbaric oxygen therapy (hot) as an otoprotection agent against cisplatin ototoxicity

Acta Cirurgica Brasileira

Volumn 23, Issue SUPPL., 2008, Pages 72-76

  Yassuda, Camila C ^a   Righetti, Ana Elisa M ^a   Cury, Maria Cristina L ^a   Hyppolito, Miguel Ângelo ^a   De Oliveira, José Antonio A ^a   Féres, Omar ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Cisplatin; Hyperbaric oxygen therapy; Otoprotection; Ototoxicity

Indexed keywords

CISPLATIN;

ACOUSTICS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAZIL; COCHLEA; CONTROLLED STUDY; EAR PROTECTION; EXPERIMENTAL STUDY; GUINEA PIG; HAIR CELL; HEARING LOSS; HYPERBARIC OXYGEN; MEDICAL SCHOOL; NONHUMAN; OTOTOXICITY; SCANNING ELECTRON MICROSCOPY; TOXICITY;

ANIMALS; ANTINEOPLASTIC AGENTS; CELL RESPIRATION; CISPLATIN; COCHLEA; DISEASE MODELS, ANIMAL; GUINEA PIGS; HAIR CELLS, AUDITORY; HEARING LOSS; HYPERBARIC OXYGENATION; MITOCHONDRIA; OXYGEN CONSUMPTION;

EID: 44449168617     PISSN: 01028650     EISSN: 16782674     Source Type: Journal    
DOI: 10.1590/S0102-86502008000700013     Document Type: Article

References (26)

1. Oliveira JAA, Canedo DM, Rossato M. Otoprotection of auditory hair cell against amikacin ototoxicity. Rev Bras Otorrinolaringol. 2002;68:7-13.
2. Stadinicki SW, Gleichman RW, Schaaeppi U. Ototoxicity of Cisdichlorommine Platinum (II) (NSC -119875): Hearing loss and Other Toxic Effects in Rhesus Monkeys. Can Chemother. 1975;59:467-80.
3. Laurell G, Engström B. Bagger- Sjöback D. Ototoxity of cisplatin. Int J Androl. 1987;10:359-62.
4. Powis GD, Hacker MP. The Toxicity of anticancer drugs. Peragamon Press, New York, 1991; p 82-105.
5. Wright CG, Schaeffer SD. Inner ear hystophatology in patiennts treated with cisplatin. Laringoscope. 1982;92:1408-13.
6. Saito T, Aran JM. Comparative ototoxicity of cisplatin during acute and chronic treatment. ORL J Otorhinolaryngol Relat Spec. 1994;56:315-20.
7. Barron SE, Daigneault EA. Effect of cisplatin on hair cell morphology and lateral wall Na,K-ATPase activity. Hear Res. 1987;26:131-7.
8. Kohn S, Fradis M, Podoshin L, Bem David Y, Zidan J, Robinson E, Nir I. Toxic effects of ciplatin alone and in combination with gentamicin in stria vascularis of guinea pigs. The Larymgoscope. 1991;101:709-16.
9. Laurell G, Engström B. The Ototoxic Effect of Ciplatin in Guinea Pigs in Relation to Dosage. Hearing Res. 1989;38:27-34.
10. Janning MH, Withworth CA, Rybak LP. Experimental model of cisplatin ototxicity in chinchilas. Otolaryngol Head Neck Surg. 1998;119:574-80.
11. Stengs CH, Klis SF, Huizing EH, Smmorenburg GF. Protective effects of a neurothophic ACTH (4-9) analog on cisplatin ototoxicity in relation to the cisplatin dose: an electrocochleogarphic study in albino guine pigs. Hear Res. 1998;124:108-17.
12. Cardinaal RM, Groot JCMJ, Huizing EH, Veldman JE, Smmorenbrg GF. Dose- depend effect of 8-day ciplatin administration upon the morphology of the albino guinea pig cochlea. Hear Res. 2000;144:135-46.
13. Sockalingam R, Freeman S, Cherny TL, Sohmer H. Effect of high- dose ciplatin on auditory brainstem responses and otoacoustic emissions in laboratory animals. Am J Otol. 2000;21:521-7.
14. Rybak LP, Radhika R, Somani SM. Mechanism of protection by diethyldithiocarbamate against cisplatin ototxicity: Antioxidant System. Fundamental and Apllied Toxicology. 1995;26:293-300.
15. Rybak LP, Whitworth MA, Somani S. Application of Antioxidants and Other Agents to Prevent Ciplatin Ototoxicity. The Laryngoscope. 1999;109:1740-4.
16. Heijmen PS, Klis SF, De Groot JC, Smoorenburg GF. Cisplatin ototoxicity and the possibly protective effect of alpha-melanocyte stimulatong hormone. Hearing Res. 1999;128:27-39.
17. Jordan JA, Schwade ND, Truelson JM. Fosfomycin does not inhibit the tumoricidal efficacy of cisplatinum. The Laryngoscope. 1999;109:1259-62.
18. Fukaya H, Kanno H. Experimental studies of the protective effect of ginkgo biloba extract (GBE) on cisplatin- induced toxicity in rats. Nippon Jibiinkoka Gakkai Kaiho. 1999;102:907-17.
19. Cardinaal RM, Groot JCMJ, Huizing EH, Veldman JE, Smoorenburg GF. Histological effects of Co-administration of an ACTH(4-9) analog, ORG 2766, on cisplatin ototocity in the albino guinea pig. Hear Res. 2000;144:157-67.
20. Lopez-Gonzalez MA, Guerrero JM, Rojas F, Delgado F. Ototocity caused by cisplatin is ameliorated by melatonin and other antioxidants. J Pineal Res Copenhagen. 2000;28:73-80.
21. Sheridan RL, Shank ES. Hyperbaric oxygen treatment: a brief overview of a controversial topic. J Trauma. 1999;47:426-35.
22. Zamboni WA, Roth AC, Russel RC, Graham B, Suchy H, Kucan JO. Morphologic analysis of the microcirculation during reperfusion of ischemic skeletal muscle and effect of hyperbaric oxygen. Plast Reconstr Surg. 1993;91:1110-23.
23. Buras J. Basic mechanisms of hyperbaric oxygen in the treatment of ischemia-reperfusion injury. In: HBO Symposium; South Carolina, 1999.
24. Yasar M, Yildiz S, Mas R, Dundar K, Korkmaz A. The effect of hyperbaric oxygen treatment on oxidative stress in experimental acute necrotizing pancreatitis. Physiol Res. 2003;52:111-6.
25. Jero J, Coling DE, Lawani AK. The use of Preyer's reflex in evaluation of hearing in mice. Acta Otolaryngol. 2001;121:585-9.
26. Hyppolito MA. Ototoxicidade pela cisplatina: autodefesa das células ciliadas externas e otoproteção pelo extrato de Ginkgo biloba (EGB 761) e salicilato de sódio. Tese apresentada à Faculdade de Medicina de Ribeirão Preto da Universidade de São Paulo, para a obtenção do título de Doutor em Medicina, Programa de Oftalmologia, 2004